163 related articles for article (PubMed ID: 30557227)
1. Overview in the clinical management of patients with seronegative villous atrophy.
Schiepatti A; Sanders DS; Zuffada M; Luinetti O; Iraqi A; Biagi F
Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):409-417. PubMed ID: 30557227
[TBL] [Abstract][Full Text] [Related]
2. Enteropathies with villous atrophy but negative coeliac serology in adults: current issues.
Schiepatti A; Cincotta M; Biagi F; Sanders DS
BMJ Open Gastroenterol; 2021 Nov; 8(1):. PubMed ID: 34764141
[TBL] [Abstract][Full Text] [Related]
3. Seronegative coeliac disease: clearing the diagnostic dilemma.
Schiepatti A; Sanders DS; Biagi F
Curr Opin Gastroenterol; 2018 May; 34(3):154-158. PubMed ID: 29613916
[TBL] [Abstract][Full Text] [Related]
4. Seronegative celiac disease: Shedding light on an obscure clinical entity.
Volta U; Caio G; Boschetti E; Giancola F; Rhoden KJ; Ruggeri E; Paterini P; De Giorgio R
Dig Liver Dis; 2016 Sep; 48(9):1018-22. PubMed ID: 27352981
[TBL] [Abstract][Full Text] [Related]
5. Short article: Mortality and differential diagnoses of villous atrophy without coeliac antibodies.
Schiepatti A; Biagi F; Fraternale G; Vattiato C; Balduzzi D; Agazzi S; Alpini C; Klersy C; Corazza GR
Eur J Gastroenterol Hepatol; 2017 May; 29(5):572-576. PubMed ID: 28350748
[TBL] [Abstract][Full Text] [Related]
6. The Role of the Gluten-Free Diet in the Management of Seronegative Enteropathy.
Szaflarska-Popławska A
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836279
[TBL] [Abstract][Full Text] [Related]
7. Clinical classification and long-term outcomes of seronegative coeliac disease: a 20-year multicentre follow-up study.
Schiepatti A; Rej A; Maimaris S; Cross SS; Porta P; Aziz I; Key T; Goodwin J; Therrien A; Yoosuf S; Leffler DA; Silvester JA; Klersy C; Biagi F; Sanders DS
Aliment Pharmacol Ther; 2021 Nov; 54(10):1278-1289. PubMed ID: 34496060
[TBL] [Abstract][Full Text] [Related]
8. Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris consensus.
Schiepatti A; Sanders DS; Baiardi P; Caio G; Ciacci C; Kaukinen K; Lebwohl B; Leffler D; Malamut G; Murray JA; Rostami K; Rubio-Tapia A; Volta U; Biagi F
Gut; 2022 Nov; 71(11):2218-2225. PubMed ID: 35676085
[TBL] [Abstract][Full Text] [Related]
9. Gamma delta
Fernández-Bañares F; Crespo L; Núñez C; López-Palacios N; Tristán E; Vivas S; Farrais S; Arau B; Vidal J; Roy G; Esteve M
Aliment Pharmacol Ther; 2020 Apr; 51(7):699-705. PubMed ID: 32048756
[TBL] [Abstract][Full Text] [Related]
10. All that glitters is not always gold.
Harrison E; Hayes S; Howell L; Lal S
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24515230
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against deamidated gliadin peptides in early-stage celiac disease.
Kurppa K; Lindfors K; Collin P; Saavalainen P; Partanen J; Haimila K; Huhtala H; Laurila K; Mäki M; Kaukinen K
J Clin Gastroenterol; 2011 Sep; 45(8):673-8. PubMed ID: 21063208
[TBL] [Abstract][Full Text] [Related]
12. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy.
Abrams JA; Diamond B; Rotterdam H; Green PH
Dig Dis Sci; 2004 Apr; 49(4):546-50. PubMed ID: 15185855
[TBL] [Abstract][Full Text] [Related]
13. The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000-2015).
Aziz I; Peerally MF; Barnes JH; Kandasamy V; Whiteley JC; Partridge D; Vergani P; Cross SS; Green PH; Sanders DS
Gut; 2017 Sep; 66(9):1563-1572. PubMed ID: 27605538
[TBL] [Abstract][Full Text] [Related]
14. Optimising delivery of care in coeliac disease - comparison of the benefits of repeat biopsy and serological follow-up.
Sharkey LM; Corbett G; Currie E; Lee J; Sweeney N; Woodward JM
Aliment Pharmacol Ther; 2013 Nov; 38(10):1278-91. PubMed ID: 24117503
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune enteropathy and villous atrophy in adults.
Corazza GR; Biagi F; Volta U; Andreani ML; De Franceschi L; Gasbarrini G
Lancet; 1997 Jul; 350(9071):106-9. PubMed ID: 9228963
[TBL] [Abstract][Full Text] [Related]
16. [Celiac disease].
Malamut G; Cellier C
Rev Med Interne; 2010 Jun; 31(6):428-33. PubMed ID: 20359791
[TBL] [Abstract][Full Text] [Related]
17. Reversal of IgM deficiency following a gluten-free diet in seronegative celiac disease.
Montenegro L; Piscitelli D; Giorgio F; Covelli C; Fiore MG; Losurdo G; Iannone A; Ierardi E; Di Leo A; Principi M
World J Gastroenterol; 2014 Dec; 20(46):17686-9. PubMed ID: 25516687
[TBL] [Abstract][Full Text] [Related]
18. Management of Small Bowel Villous Atrophy in Patients Seronegative for Celiac Disease.
Jansson-Knodell CL; Murray JA; Rubio-Tapia A
Am J Gastroenterol; 2020 Apr; 115(4):492-497. PubMed ID: 32141915
[No Abstract] [Full Text] [Related]
19. [Update on Current Care guidelines: coeliac disease].
;
Duodecim; 2011; 127(3):296-7. PubMed ID: 21438352
[TBL] [Abstract][Full Text] [Related]
20. [Etiological diagnosis of villous atrophy].
Patey-Mariaud De Serre N; Verkarre V; Cellier C; Cerf-Bensussan N; Schmitz J; Brousse N
Ann Pathol; 2001 Aug; 21(4):319-33. PubMed ID: 11685130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
